Clinical Trials in Philadelphia

Showing 6661-6680 of 15,860 trials

Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

NCT02207439

This is a Phase II trial of definitive chemoradiotherapy (CTRT) given with the protease inhibitor,Nelfinavir (NFV), in patients with locally advanced head and neck. Eligible patients will receive a "lead-in" period of Nelfinavir (1250 mg po bid) for 7-14 days prior to initiation of CTRT. Nelfinavir will then be given concurrently with platinum-based chemotherapy and radiation therapy (planned total dose of 70 Gy over 7 weeks).

Head and Neck Squamous Cell Carcinoma

Abramson Cancer Center at Penn Medicine18 participantsStarted Jul 2014

Philadelphia, Pennsylvania, United States

TERMINATEDPhase 4< 1 mile

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

NCT05119439

This study seeks to evaluate the efficacy, side effect profile and acceptability of a medical abortion regimen with mifepristone and two doses of 800 mcg misoprostol buccally at 71-77 and 78-84 days of gestation to further expand the evidence base for the most effective regimens in the late first trimester of pregnancy.

Medical Abortion

Gynuity Health Projects23 participantsStarted Oct 2022

Hilo, Hawaii, United States • Honolulu, Hawaii, United States • Saint Paul, Minnesota, United States +3 more locations

Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

Find Trials by Condition in Philadelphia

Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients

A Randomized Controlled Trial of Imago Relationship Therapy

First in Human Study to Evaluate the Safety and Tolerability of EYP-1901 in Patients With Wet Age Related Macular Degeneration (wAMD)

A Trial of Tisotumab Vedotin in Cervical Cancer

Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG

Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

Registry for Proton Beam Radiation Therapy

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder

Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia

A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression

A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)

Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis

Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis

Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease

Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014)